Filgrastim Completed Phase 2 Trials for Cancer, Bladder / Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00028860Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer